Abstract:We have studied the involvement of the 5' cap structure in the splicing of precursor mRNAs in a HeLa nuclear extract. We show that precursor mRNAs are spliced efficiently only when they possess a cap structure and that preincubation of a HeLa nuclear extract rendered the splicing reaction highly sensitive to inhibition by cap analogues. This sensitization was dependent on exogenous Mg2' but not exogenous ATP or GTP.These results demonstrate that splicing in a nuclear extract is highly dependent on the cap stru… Show more
“…The cap appears to earmark an RNA molecule for processes that are specific to Pol II transcripts. It enhances splicing, 3Ј processing, transport, and translation of mRNA (Konarska et al 1984;Edery and Sonenberg 1985;Shatkin 1985;Gilmartin et al 1988;Hamm and Mattaj 1990;Izaurralde et al 1994;Colot et al 1996;Cooke and Alwine 1996). The cap also stabilizes mRNA (Furuichi et al 1977;Green et al 1983); moreover, decapping is important for triggering degradation (Beelman and Parker 1995).…”
mentioning
confidence: 99%
“…Previous experiments have not addressed whether capping is also integrated with transcription by a mechanism involving the CTD. Because the 5Ј cap stimulates splicing and polyadenylation (Edery and Sonenberg 1985;Izaurralde et al 1994;Cooke and Alwine 1996), it remains possible that a capping defect could contribute to reduced processing of transcripts made by Pol II with a truncated CTD. In this paper, we show that CTD truncation does, in fact, reduce mRNA capping in vivo, although this effect cannot fully account for the splicing and polyadenylation defects of transcripts made by the truncated Pol II.…”
We have investigated the role of the RNA Polymerase II (Pol II) carboxy-terminal domain (CTD) in mRNA 5 capping. Transcripts made in vivo by Pol II with a truncated CTD had a lower proportion of capped 5 ends than those made by Pol II with a full-length CTD. In addition, the enzymes responsible for cap synthesis, RNA guanylyltransferase, and RNA (guanine-7)-methyltransferase bound directly to the phosphorylated, but not to the nonphosphorylated, form of the CTD in vitro. These results suggest that: (1) Pol II-specific capping of nascent transcripts in vivo is enhanced by recruitment of the capping enzymes to the CTD and (2) capping is co-ordinated with CTD phosphorylation.
“…The cap appears to earmark an RNA molecule for processes that are specific to Pol II transcripts. It enhances splicing, 3Ј processing, transport, and translation of mRNA (Konarska et al 1984;Edery and Sonenberg 1985;Shatkin 1985;Gilmartin et al 1988;Hamm and Mattaj 1990;Izaurralde et al 1994;Colot et al 1996;Cooke and Alwine 1996). The cap also stabilizes mRNA (Furuichi et al 1977;Green et al 1983); moreover, decapping is important for triggering degradation (Beelman and Parker 1995).…”
mentioning
confidence: 99%
“…Previous experiments have not addressed whether capping is also integrated with transcription by a mechanism involving the CTD. Because the 5Ј cap stimulates splicing and polyadenylation (Edery and Sonenberg 1985;Izaurralde et al 1994;Cooke and Alwine 1996), it remains possible that a capping defect could contribute to reduced processing of transcripts made by Pol II with a truncated CTD. In this paper, we show that CTD truncation does, in fact, reduce mRNA capping in vivo, although this effect cannot fully account for the splicing and polyadenylation defects of transcripts made by the truncated Pol II.…”
We have investigated the role of the RNA Polymerase II (Pol II) carboxy-terminal domain (CTD) in mRNA 5 capping. Transcripts made in vivo by Pol II with a truncated CTD had a lower proportion of capped 5 ends than those made by Pol II with a full-length CTD. In addition, the enzymes responsible for cap synthesis, RNA guanylyltransferase, and RNA (guanine-7)-methyltransferase bound directly to the phosphorylated, but not to the nonphosphorylated, form of the CTD in vitro. These results suggest that: (1) Pol II-specific capping of nascent transcripts in vivo is enhanced by recruitment of the capping enzymes to the CTD and (2) capping is co-ordinated with CTD phosphorylation.
“…It is of particular importance in translation, at the initiation level (see references 14 and 51 for reviews). The cap also facilitates mRNA splicing (15,28) and 3' end processing (19,25) and is required for nucleocytoplasmic RNA transport (24). In addition, the cap protects mRNA against 5'-3' exonucleolytic degradation (18,21).…”
The eukaryotic mRNA 5' cap structure m7GpppX (where X is any nucleotide) interacts with a number of cellular proteins. Several of these proteins were studied in mammalian, yeast, and drosophila cells and found to be involved in translation initiation. Here we describe a novel cap-binding protein, the coat protein of L-A, a double-stranded RNA virus that is persistently maintained in many Saccharomyces cerevisiae strains. The results also suggest that the coat protein of a related double-stranded RNA virus (L-BC) is likewise a cap-binding protein. Strikingly, in contrast to the cellular cap-binding proteins, the interaction between the L-A virus coat protein and the cap structure is through a covalent bond.All eukaryotic cellular mRNAs (except for organellar mRNAs) possess the 5' structure m7GpppX (where X is any nucleotide), termed cap. The cap structure plays important roles in several cytoplasmic and nuclear processes.
“…Since in vitro splicing systems were developed, considerable progress has been made in understanding the mechanism of nuclear precursor mRNA (premRNA) splicing (for review, see Green 1986;Padgett et al 1986;Sharp 1987). A cap structure, m^G(5')ppp(5')N, blocking the 5' termini of many eukaryotic mRNAs has been shown to play an important role in pre-mRNA splicing (Krainer et al 1984;Konarska et al 1984;Edery and Sonenberg 1985;Ohno et al 1987). Although the requirement for the cap appears to differ slightly between whole-cell and nuclear extracts (Konarska et al 1984: Edery andSonenberg 1985), the results obtained with the in vitro splicing reaction indicate that cap recognition is an important event in the early process of the splicing reaction.…”
mentioning
confidence: 99%
“…A cap structure, m^G(5')ppp(5')N, blocking the 5' termini of many eukaryotic mRNAs has been shown to play an important role in pre-mRNA splicing (Krainer et al 1984;Konarska et al 1984;Edery and Sonenberg 1985;Ohno et al 1987). Although the requirement for the cap appears to differ slightly between whole-cell and nuclear extracts (Konarska et al 1984: Edery andSonenberg 1985), the results obtained with the in vitro splicing reaction indicate that cap recognition is an important event in the early process of the splicing reaction. By use of pre-mRNAs that contain three exons and two introns, we have shown that when a pre-mRNA is capped, the upstream intron is spliced out more efficiently than the downstream intron because of the differential effect of the cap structure on the two introns.…”
The effect of the 5' cap structure on the splicing of precursor mRNAs was investigated after the RNAs were injected into Xenopus oocyte nuclei. The precursor mRNAs synthesized in vitro in a prokaryotic transcription system with a dinucleotide, ApppG, as a primer, were extremely stable when injected into the nuclei yet behaved like uncapped pre-mRNAs in the in vitro splicing reaction. The ApppG-primed precursor mRNAs served as a control (uncapped) in the injection experiments, and their splicing reactions were compared with those of their capped (m^GpppG-primed) counterparts. The capped precursors were spliced more efficiently than the uncapped precursors. Examination of splicing of the precursor mRNA that contained three exons and two introns within a single molecule has revealed that the cap structure exerts its effect primarily on the 5'-proximal intron. Thus, the cap structure not only stabilizes precursor mRNAs but also plays a positive role in the splicing of precursor mRNAs in cells.[Key Words: Xenopus oocyte; microinjection; pre-mRNA splicing; cap structure] Received September 9, 1988; revised version accepted fune 13, 1989. Since in vitro splicing systems were developed, considerable progress has been made in understanding the mechanism of nuclear precursor mRNA (premRNA) splicing (for review, see Green 1986;Padgett et al. 1986;Sharp 1987). A cap structure, m^G(5')ppp(5')N, blocking the 5' termini of many eukaryotic mRNAs has been shown to play an important role in pre-mRNA splicing (Krainer et al. 1984;Konarska et al. 1984;Edery and Sonenberg 1985;Ohno et al. 1987). Although the requirement for the cap appears to differ slightly between whole-cell and nuclear extracts (Konarska et al. 1984: Edery andSonenberg 1985), the results obtained with the in vitro splicing reaction indicate that cap recognition is an important event in the early process of the splicing reaction. By use of pre-mRNAs that contain three exons and two introns, we have shown that when a pre-mRNA is capped, the upstream intron is spliced out more efficiently than the downstream intron because of the differential effect of the cap structure on the two introns. We have also shown that the cap structure exerts its effect primarily on the 5'-proximal intron . The aforementioned effect of the cap structure on pre-mRNA splicing was studied solely in in vitro systems, and it is not entirely clear whether the findings obtained in in vitro systems also apply to cells. It has been argued that one in vivo function of the cap is primarily to stabilize pre-mRNA molecules in the nucleus and that the in vivo role of the cap in splicing still remains to be clarified (Green 1986). One problem encountered in the in vivo study of cap function is that uncapped pre-mRNA is degraded rapidly upon injection into nuclei (Green et al. 1983), and consequently, comparative studies of the in vivo splicing reaction of capped pre-mRNA and that of its uncapped counterpart have been difficult. We undertook a close examination of the in vivo role of the cap in pre-m...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.